A comprehensive review of infection risk in patients on targeted and biologic therapies for rheumatoid or psoriatic arthritis has reinforced the complexity of attributing risk to specific agents. The review, published in Annals of the Rheumatic Diseases, notes that RA and PsA per se are associated with an increased infectious risk and highlights the additional ...
Experts give their views on infection risk with biologics
By Mardi Chapman
8 Oct 2020